Amin H, Marinaro F, De Pietri Tonelli D, Berdondini L (2017) Developmental excitatory-to-inhibitory GABA-polarity switch is disrupted in 22q11.2 deletion syndrome: a potential target for clinical therapeutics. Rep, Sci. https://doi.org/10.1038/s41598-017-15793-9

Book  Google Scholar 

Andersen JV (2025) The glutamate/ GABA-glutamine cycle: insights, updates, and advances. J Neurochem 169:e70029. https://doi.org/10.1111/jnc.70029

Article  CAS  PubMed  PubMed Central  Google Scholar 

Andersen JV, Schousboe A, Verkhratsky A (2022) Astrocyte energy and neurotransmitter metabolism in Alzheimer’s disease: integration of the glutamate/GABA-glutamine cycle. Prog Neurobiol 217:102331. https://doi.org/10.1016/j.pneurobio.2022.102331

Article  CAS  PubMed  Google Scholar 

Araque A, Carmignoto G, Haydon PG, Oliet SHR, Robitaille R, Volterra A (2014) Gliotransmitters travel in time and space. Neuron 81:728–739. https://doi.org/10.1016/j.neuron.2014.02.007

Article  CAS  PubMed  PubMed Central  Google Scholar 

Auvin S, Jeljeli M, Desnous B, Soussi-Yanicostas N, Dournaud P, Sterkers G (2018) Altered vaccine-induced immunity in children with Dravet syndrome. Epilepsia. https://doi.org/10.1111/epi.14038

Article  PubMed  Google Scholar 

Bazelot M, Whalley B (2016) Investigating the involvement of GPR55 signaling in the antiepileptic effects of cannabidiol (P5. 244). Neurology 86:244

Article  Google Scholar 

Bisogno T, Hanuš L, De Petrocellis L, Tchilibon S, Ponde DE, Brandi I, Moriello AS, Davis JB, Mechoulam R, Di Marzo V (2001) Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. Br J Pharmacol 134:845–852

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brenet A, Somkhit J, Csaba Z, Ciura S, Kabashi E, Yanicostas C, Soussi-Yanicostas N (2024) Microglia mitigate neuronal activation in a zebrafish model of Dravet syndrome. Cells 13:684. https://doi.org/10.3390/cells13080684

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brickley SG, Mody I (2012) Extrasynaptic GABAA receptors: their function in the CNS and implications for disease. Neuron 73:23–34. https://doi.org/10.1016/j.neuron.2011.12.012

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brown A, Arpone M, Schneider AL, Micallef S, Anderson VA, Scheffer IE (2020) Cognitive, behavioral, and social functioning in children and adults with Dravet syndrome. Epilepsy Behav. https://doi.org/10.1016/j.yebeh.2020.107319

Article  PubMed  PubMed Central  Google Scholar 

Castillo A, Tolón MR, Fernández-Ruiz J, Romero J, Martinez-Orgado J (2010) The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic–ischemic brain damage in mice is mediated by CB2 and adenosine receptors. Neurobiol Dis 37:434–440

Article  CAS  PubMed  Google Scholar 

Catterall WA, Kalume F, Oakley JC (2010) NaV1.1 channels and epilepsy. J Physiol 588:1849–1859. https://doi.org/10.1113/jphysiol.2010.187484

Article  CAS  PubMed  PubMed Central  Google Scholar 

Catterall WA, Kalume F, Oakley JC (2010) NaV 1.1 channels and epilepsy: NaV 1.1 channels and epilepsy. J Physiol 588:1849–1859. https://doi.org/10.1113/jphysiol.2010.187484

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cha J, Filatov G, Smith SJ, Gammaitoni AR, Lothe A, Reeder T (2024) Fenfluramine increases survival and reduces markers of neurodegeneration in a mouse model of Dravet syndrome. Epilepsia Open 9:300–313. https://doi.org/10.1002/epi4.12873

Article  PubMed  Google Scholar 

Chen I-C, Ho S-Y, Tsai C-W, Chen E-L, Liou H-H (2024) Microglia-impaired phagocytosis contributes to the epileptogenesis in a mouse model of Dravet syndrome. Int J Mol Sci 25:12721. https://doi.org/10.3390/ijms252312721

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen Z-P, Zhao X, Wang S, Cai R, Liu Q, Ye H, Wang M-J, Peng S-Y, Xue W-X, Zhang Y-X, Li W, Tang H, Huang T, Zhang Q, Li L, Gao L, Zhou H, Hang C, Zhu J-N, Li X, Liu X, Cong Q, Yan C (2025) GABA-dependent microglial elimination of inhibitory synapses underlies neuronal hyperexcitability in epilepsy. Nat Neurosci. https://doi.org/10.1038/s41593-025-01979-2

Article  PubMed  PubMed Central  Google Scholar 

Chilcott E, Díaz JA, Bertram C, Berti M, Karda R (2022) Genetic therapeutic advancements for Dravet Syndrome. Epilepsy Behav 132:108741. https://doi.org/10.1016/j.yebeh.2022.108741

Article  PubMed  Google Scholar 

Claes L, Del-Favero J, Ceulemans B, Lagae L, Van Broeckhoven C, De Jonghe P (2001) De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet 68:1327–1332

Article  CAS  PubMed  PubMed Central  Google Scholar 

Corradini I, Focchi E, Rasile M, Morini R, Desiato G, Tomasoni R, Lizier M, Ghirardini E, Fesce R, Morone D, Barajon I, Antonucci F, Pozzi D, Matteoli M (2018) Maternal immune activation delays excitatory-to-inhibitory gamma-aminobutyric acid switch in offspring. Biol Psychiatry 83:680–691. https://doi.org/10.1016/j.biopsych.2017.09.030

Article  CAS  PubMed  Google Scholar 

Crowley T, Cryan JF, Downer EJ, O’Leary OF (2016) Inhibiting neuroinflammation: the role and therapeutic potential of GABA in neuro-immune interactions. Brain Behav Immun 54:260–277. https://doi.org/10.1016/j.bbi.2016.02.001

Article  CAS  PubMed  Google Scholar 

De Stasi AM, Farisello P, Marcon I, Cavallari S, Forli A, Vecchia D, Losi G, Mantegazza M, Panzeri S, Carmignoto G, Bacci A, Fellin T (2016) Unaltered network activity and interneuronal firing during spontaneous cortical dynamics in vivo in a mouse model of severe myoclonic epilepsy of infancy. Cereb Cortex 26:1778–1794. https://doi.org/10.1093/cercor/bhw002

Article  PubMed  PubMed Central  Google Scholar 

Deidda G, Parrini M, Naskar S, Bozarth IF, Contestabile A, Cancedda L (2015) Reversing excitatory GABAAR signaling restores synaptic plasticity and memory in a mouse model of Down syndrome. Nat Med 21:318–326. https://doi.org/10.1038/nm.3827

Article  CAS  PubMed  Google Scholar 

Devinsky O, Nabbout R, Miller I, Laux L, Zolnowska M, Wright S, Roberts C (2019) Long-term cannabidiol treatment in patients with Dravet syndrome: an open-label extension trial. Epilepsia 60:294–302

Article  CAS  PubMed  Google Scholar 

Di Berardino C, Massimino L, Ungaro F, Colasante G (2024) Gene therapy for Dravet syndrome: promises and impact on disease trigger and secondary modifications. Orphan Drugs J, Rare Dis. https://doi.org/10.20517/rdodj.2024.07

Book  Google Scholar 

Ding J, Li X, Tian H, Wang L, Guo B, Wang Y, Li W, Wang F, Sun T (2021) SCN1A mutation—beyond Dravet syndrome: a systematic review and narrative synthesis. Front Neurol. https://doi.org/10.3389/fneur.2021.743726

Article  PubMed  PubMed Central  Google Scholar 

Dravet C (2011) The core Dravet syndrome phenotype. Epilepsia 52:3–9. https://doi.org/10.1111/j.1528-1167.2011.02994.x

Article  PubMed  Google Scholar 

Duflocq A, Le Bras B, Bullier E, Couraud F, Davenne M (2008) Nav1.1 is predominantly expressed in nodes of Ranvier and axon initial segments. Mol Cell Neurosci 39:180–192. https://doi.org/10.1016/j.mcn.2008.06.008

Article  CAS  PubMed  Google Scholar 

Durkee CA, Covelo A, Lines J, Kofuji P, Aguilar J, Araque A (2019) Gi/o protein-coupled receptors inhibit neurons but activate astrocytes and stimulate gliotransmission. Glia 67:1076–1093. https://doi.org/10.1002/glia.23589

Article  PubMed  PubMed Central